Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MEBO International is a global leader in regenerative medicine, founded in 1987 by Dr. Rongxiang Xu. The company is built upon the Human Body Regenerative Restoration Science (HBRRS) platform, which focuses on activating the body's innate regenerative potential through specific nutritional substances. Its flagship product, Moist Exposed Burn Ointment (MEBO), is used worldwide for the physiological healing of burns and wounds without the need for skin grafts. Beyond wound care, the company has expanded into gastrointestinal health, nutritional supplements, and skincare products. MEBO International maintains a significant intellectual property portfolio with hundreds of patents across the US, EU, China, and Japan. The group operates dual headquarters in California and Beijing, supporting a distribution network that spans over 70 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MEBO International.